Your browser doesn't support javascript.
loading
Preclinical study of safety and immunogenicity of combined rubella and human papillomavirus vaccines: Towards enhancing vaccination uptake rates in developing countries.
Gohar, Asmaa; Abdeltawab, Nourtan F; Shehata, Nahla; Amin, Magdy A.
Afiliación
  • Gohar A; Biotechnology Control Unit, National Organization of Research and Control of Biologicals, Cairo, Egypt. Electronic address: asma.gohar@yahoo.com.
  • Abdeltawab NF; Department of Microbiology and Immunology, Faculty of Pharmacy, Cairo University, Cairo, Egypt. Electronic address: nourtan.abdeltawab@pharma.cu.edu.eg.
  • Shehata N; Biotechnology Control Unit, National Organization of Research and Control of Biologicals, Cairo, Egypt. Electronic address: lr_egy@yahoo.com.
  • Amin MA; Department of Microbiology and Immunology, Faculty of Pharmacy, Cairo University, Cairo, Egypt. Electronic address: magdy_biotek3@yahoo.com.
Papillomavirus Res ; 8: 100172, 2019 12.
Article en En | MEDLINE | ID: mdl-31185296

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Rubéola (Sarampión Alemán) / Vacuna contra la Rubéola / Infecciones por Papillomavirus / Vacunas contra Papillomavirus / Inmunogenicidad Vacunal Límite: Animals / Female / Humans Idioma: En Revista: Papillomavirus Res Año: 2019 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Rubéola (Sarampión Alemán) / Vacuna contra la Rubéola / Infecciones por Papillomavirus / Vacunas contra Papillomavirus / Inmunogenicidad Vacunal Límite: Animals / Female / Humans Idioma: En Revista: Papillomavirus Res Año: 2019 Tipo del documento: Article